Comparative evaluation of efficacy of hydroxyapatite and ß-tricalcium phosphate (Biograft-HT®) with or without type 1 collagen membrane (Cologide™) in the treatment of intrabony defects in molars: A clinico-radiographic study

2018 ◽  
Vol 8 (1) ◽  
pp. 26
Author(s):  
Gazal Jain ◽  
Deepa Dhruvakumar ◽  
Amit Wadhawan
Keyword(s):  
Tricalcium Phosphate ◽  
Comparative Evaluation ◽  
Collagen Membrane ◽  
Radiographic Study ◽  
Intrabony Defects

scholarly journals Evaluation of Relative Efficacy of β-Tricalcium Phosphate with and without Type I Resorbable Collagen Membrane in Periodontal Infrabony Defects: A Clinical and Radiographic Study

2013 ◽  
Vol 14 (2) ◽  
pp. 193-201 ◽  
Author(s):  
R Padma ◽  
D Trinath Kishore ◽  
Tushar Bandiwadekar ◽  
Surangama Debunath ◽  
Profulla LNU ◽  
...  
Keyword(s):  
Tricalcium Phosphate ◽  
Statistical Significance ◽  
Collagen Membrane ◽  
Type I ◽  
Clinical Parameters ◽  
Relative Efficacy ◽  
Radiographic Study ◽  
Experimental Site ◽  
Radiographic Findings ◽  
Infrabony Defects

ABSTRACT Background and objectives To compare clinically and radiographically, the regenerative potential of a β-tricalcium phosphate bone graft, Cerasorb® with and without a bioresorbable type I collagen membrane, BioMend ExtendTM, in treating periodontal infrabony osseous defects. Materials and methods A total of 20 sites from 10 patients showing bilateral infrabony defects were selected and selected sites were randomly divided into experimental site A (Cerasorb®) and experimental site B (Cerasorb® and BioMend ExtendTM) by using split mouth design. The clinical parameters like plaque index, gingival index, probing pocket depth, clinical attachment level and gingival recession were recorded at baseline, 6 weeks, 3, 6 and 9 months. Radiographic evaluation (Linear CADIA) at 6 and 9 months; and intrasurgical measurements at baseline and 9 months were carried out to evaluate the defect fill, change in alveolar crest height and defect resolution. Results Significant reduction in all clinical parameters was observed in both the groups. On comparison no statistical significance was observed between the two groups. Radiographically, in site A there was significant defect fill of 78.4 and 97.2% at 6 and 9 months respectively. Whereas in site B reduction was 78.4 and 97.2% at 6 and 9 months respectively. After surgical re-entry, there was significant defect fill of 89.2 and 74% in both groups. Interpretation and conclusion Individually both the graft and membrane have shown promising results in the management of periodontal intrabony defects. But the added benefit by combining Cerasorb® with BioMend ExtendTM was not observed statistically in both clinical radiographic findings. How to cite this article Kishore DT, Bandiwadekar T, Padma R, Debunath S, Profulla, Reddy A. Evaluation of Relative Efficacy of β-Tricalcium Phosphate with and without Type I Resorbable Collagen Membrane in Periodontal Infrabony Defects: A Clinical and Radiographic Study. J Contemp Dent Pract 2013;14(2): 193-201.

scholarly journals Surgical Treatment of Periodontal Intrabony Defects with Calcium Sulphate in Combination with Beta Tricalcium Phosphate – A 12-Month Retrospective Clinical Evaluation

2010 ◽  
Vol 53 (4) ◽  
pp. 229-234 ◽  
Author(s):  
Sujith Sukumar ◽  
Ivo Dřízhal ◽  
Josef Bukač ◽  
Vladimíra Paulusová ◽  
Shriharsha Pilathadka
Keyword(s):  
Tissue Regeneration ◽  
Tricalcium Phosphate ◽  
Gingival Recession ◽  
Calcium Sulphate ◽  
Intrabony Defects ◽  
Clinical Attachment Level ◽  
Beta Tricalcium Phosphate ◽  
Probing Depth ◽  
One Year ◽  
Attachment Level

Alloplastic bone graft materials are widely been used in combination with barrier membranes to achieve guided tissue regeneration in the treatment of periodontal intrabony defects. This study was designed to evaluate the clinical outcome of a composite material, beta tricalcium phosphate in combination with calcium sulphate in the treatment of periodontal intrabony defects. The combination of these materials is believed to aid in guided tissue regeneration owing to their properties. Thirty nine intrabony defects in 21 patients were treated with Fortoss® Vital (Biocomposites, Staffordshire, UK). Clinical parameters were evaluated including changes in probing depth, clinical attachment level/loss and gingival recession at baseline and one year postoperatively. The mean differences in measurements between the baseline and one year postoperatively are a reduction of 1.98±1.16 mm (p=0.000) in case of probing depth and a gain of 1.68±1.12 mm (p=0.000) in clinical attachment level and an increase of 0.31±0.67 mm (p=0.009) in gingival recession measurements. The study results show that the treatment with a combination of beta tricalcium phosphate and calcium sulphate led to a significantly favorable clinical improvement in periodontal intrabony defects one year postoperatively.

Sign in / Sign up

Export Citation Format

Share Document